Key facts
- This page summarizes Thomas John T.'s Form 4 filing for Physicians Realty Trust.
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Jan 2024, 17:04.
Thomas John T. - 18 Jan 2024 Form 4 Insider Report for Physicians Realty Trust
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 18 Jan 2024
- Net transaction value
- -$600,802
- SEC form
- 4
- Accepted by SEC
- 22 Jan 2024, 17:04:15 UTC
- Prior SEC filing
- 03 Mar 2023
- Next SEC filing
- 04 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher M. Bartoli, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thomas John T. filed Form 4 for Physicians Realty Trust on 22 Jan 2024.
Change
- Previous filing in this sequence was filed on 03 Mar 2023.
- Current net transaction value: -$600,802.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DOC
transaction
Common shares, $0.01 par value
Options Exercise
- Transaction value
- Shares
- +149,881
- Change %
- +25%
- Price
- Shares after
- 743,265
- Date
- 18 Jan 2024
- Ownership
- Direct
- Footnotes
- F1, F2
DOC
transaction
Common shares, $0.01 par value
Tax liability
- Transaction value
- $600,802
- Shares
- -46,394
- Change %
- -6.2%
- Price
- $12.95
- Shares after
- 696,871
- Date
- 18 Jan 2024
- Ownership
- Direct
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,217
- Date
- 18 Jan 2024
- Ownership
- Represents shares held by the Reporting Person's child
- Footnotes
- F3
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 217
- Date
- 18 Jan 2024
- Ownership
- Represents shares held by the Reporting Person's child
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 434
- Date
- 18 Jan 2024
- Ownership
- Represents shares held by the Reporting Person's child
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 87
- Date
- 18 Jan 2024
- Ownership
- Represents shares held by the Reporting Person's child
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 87
- Date
- 18 Jan 2024
- Ownership
- Represents shares held by the Reporting Person's child
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 87
- Date
- 18 Jan 2024
- Ownership
- Represents shares held by the Reporting Person's child
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 217
- Date
- 18 Jan 2024
- Ownership
- Represents shares held by the Reporting Person's child
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DOC
transaction
Derivative
2021 Performance Based Restricted Share Unit Grant
Options Exercise
- Transaction value
- $0
- Shares
- -75,392
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 18 Jan 2024
- Ownership
- Direct
- Underlying class
- Common shares, $0.01 par value
- Underlying amount
- 75,392
- Exercise price
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents vesting of the 2021 Performance Based Restricted Share Units granted on March 1, 2021 under the Issuer's Equity Incentive Plan (the "Plan"). Subject to the terms of the grant, the Reporting Person received 149,881 common shares upon vesting.
Footnote F2
Includes 1,733 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on December 29, 2023, 434 shares acquired under the Dividend Reinvestment and Share Purchase Plan, and a 5,000 share transfer to the Reporting Person's child.
Footnote F3
Includes shares transferred from the Reporting Person.
Footnote F4
On March 1, 2021, the Reporting Person was granted 75,392 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Subject to the terms of the grant, the Reporting Person received 149,881 common shares upon vesting.